-

Greenbrook TMS Announces Dates for Its First Quarter 2020 Financial Results

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its first quarter 2020 operational and financial results after market hours on May 12, 2020.

First Quarter 2020 Conference Call Details

Bill Leonard, President and Chief Executive Officer and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on May 13, 2020 to discuss the financial results for the quarter.

Dial in Numbers:

Toll Free North America: (866) 521-4909

Toronto/International: (647) 427-2311

Webcast:

For more information or to listen to the call via webcast, please visit: https://www.greenbrooktms.com/investors/events.htm

Conference Call Replay

Toll Free (North America): 1-800-585-8367

Toronto: 416-621-4642

Conference ID: 5855438

The conference call replay will be available from 1:00 p.m. (Eastern Time) on May 13, 2020, until 23:59 p.m. (Eastern Time) on June 12, 2020.

About Greenbrook TMS Inc.

Operating through 124 Company-operated treatment centers, Greenbrook is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 370,000 TMS treatments to close to 10,000 patients struggling with depression.

Contacts

Erns Loubser
Chief Financial Officer and Treasurer
Greenbrook TMS Inc.

Glen Akselrod
Investor Relations
Greenbrook TMS Inc.

Contact Information:
investorrelations@greenbrooktms.com
1-855-797-4867

Industry:

Greenbrook TMS Inc.

TSX:GTMS
Release Versions
English

Contacts

Erns Loubser
Chief Financial Officer and Treasurer
Greenbrook TMS Inc.

Glen Akselrod
Investor Relations
Greenbrook TMS Inc.

Contact Information:
investorrelations@greenbrooktms.com
1-855-797-4867

More News From Greenbrook TMS Inc.

Greenbrook TMS Announces Closing of Achieve TMS East and Central Acquisition

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the closing of the acquisition of Achieve TMS East, LLC (“Achieve TMS East”) and Achieve TMS Central, LLC (“Achieve TMS Central”, and together with Achieve TMS East, “Achieve TMS East/Central”). The initial aggregate purchase price for Achieve TMS East/Central was US$8.0 mill...

Greenbrook TMS Completes US$13.2 Million Bought Deal Public Offering

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the closing of its previously-announced public offering (the “Offering”). The Offering was made pursuant to an underwriting agreement entered into among Stifel GMP, Bloom Burton Securities Inc. and Lake Street Capital Markets, LLC (collectively, the “Underwriters”). Pursuant...

Greenbrook TMS Announces Increase to Bought Deal Financing to US$11.5 Million

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that, due to strong demand, the Company has agreed with a syndicate of underwriters co-led by Stifel GMP and Bloom Burton Securities Inc. (collectively, the “Underwriters”), to increase the size of its previously announced US$10,075,000 (or C$12,909,000) bought deal offering....
Back to Newsroom